Crossmark

In thyroxine-replaced hypothyroid postmenopausal women under simultaneous calcium supplementation, switch to oral liquid or softgel capsule l-thyroxine ensures lower serum TSH levels and favorable effects on blood pressure, total cholesterolemia and glycemia

Crossref DOI link: https://doi.org/10.1007/s12020-019-01908-x

Published Online: 2019-03-27

Published Print: 2019-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Morini, Elisabetta

Catalano, Antonino

Lasco, Antonino

Morabito, Nunziata

Benvenga, Salvatore
License Information

Text and Data Mining valid from 2019-03-27
More Information

Article History

Received: 30 January 2019

Accepted: 18 March 2019

First Online: 27 March 2019

Change Date: 28 June 2019

Change Type: Correction

Change Details: An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Compliance with ethical standards

:

: S.B. received novel formulations of LT4 from IBSA Institute Biochimique (Lugano, Switzerland) and IBSA s.r.l. (Lodi, Italy) to be given to patients for conducting clinical studies. In addition, S.B. was an invited speaker at symposia organized by IBSA. However, IBSA had no role in any phase of the writing of this manuscript. The remaining authors declare that they have no conflict of interest.

: All procedures performed in studies involving human participants were in accordance with the ethical standards of our institutional research committee at University Hospital of Messina and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

: Informed consent was obtained from all individual participants included in the study.

Updates are available Correction dated 2019-06-28

Click to view Correction: https://doi.org/10.1007/s12020-019-01979-w